Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Marcio A. Malogolowkin, MD
Children's Hospital Los Angeles
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
98 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Princess Margaret Hospital for Children
Perth, Western Australia, Australia
- Children'S & Women'S Hospital of British Columbia
Vancouver, British Columbia, Canada
- Janeway Children'S Health and Rehabilitation Centre
St. John's, Newfoundland and Labrador, Canada
- Mcmaster Children'S Hospital at Hamilton Health Sciences
Hamilton, Ontario, Canada
- Hospital for Sick Children
Toronto, Ontario, Canada
- Hopital Sainte Justine
Montreal, Quebec, Canada
- Montreal Children'S Hospital at Mcgill University Health Center
Montreal, Quebec, Canada
- Centre Hospitalier Universitaire de Quebec
Ste-Foy, Quebec, Canada
- Allan Blair Cancer Centre at Pasqua Hospital
Regina, Saskatchewan, Canada
- San Jorge Children'S Hospital
Santurce, Puerto Rico
- Comprehensive Cancer Center at University of Alabama at Birmingham
Birmingham, Alabama, United States
- Phoenix Children'S Hospital
Phoenix, Arizona, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Southern California Permanente Medical Group
Downey, California, United States
- Loma Linda University Cancer Institute at Loma Linda University Medical Center
Loma Linda, California, United States
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Children'S Hospital Central California
Madera, California, United States
- Children'S Hospital of Orange County
Orange, California, United States
- Kaiser Permanente Medical Center - Oakland
Sacramento, California, United States
- Children'S Hospital and Health Center - San Diego
San Diego, California, United States
- Stanford Cancer Center at Stanford University Medical Center
Stanford, California, United States
- Children'S Hospital Cancer Center
Denver, Colorado, United States
- Alfred I. Dupont Hospital for Children
Wilmington, Delaware, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Lee Cancer Care of Lee Memorial Health System
Fort Myers, Florida, United States
- University of Florida Shands Cancer Center
Gainesville, Florida, United States
- Nemours Children'S Clinic
Jacksonville, Florida, United States
- Baptist-South Miami Regional Cancer Program
Miami, Florida, United States
- Miami Children'S Hospital
Miami, Florida, United States
- University of Miami Sylvester Comprehensive Cancer Center
Miami, Florida, United States
- Sacred Heart Cancer Center at Sacred Heart Hospital
Pensacola, Florida, United States
- All Children'S Hospital
St. Petersburg, Florida, United States
- St. Joseph'S Cancer Institute at St. Joseph'S Hospital
Tampa, Florida, United States
- Kaplan Cancer Center at St. Mary'S Medical Center
West Palm Beach, Florida, United States
- Emory University Hospital - Atlanta
Atlanta, Georgia, United States
- Cancer Research Center of Hawaii
Honolulu, Hawaii, United States
- Children'S Memorial Hospital - Chicago
Chicago, Illinois, United States
- Saint Jude Midwest Affiliate
Peoria, Illinois, United States
- Southern Illinois University School of Medicine
Springfield, Illinois, United States
- St. Vincent Indianapolis Hospital
Indianapolis, Indiana, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2004
- Primary completion
- 30 Apr 2007
- Completion
- —
- Last update posted
- 17 Oct 2013
- Registered enrollment
- 19
- Registry id
- NCT00066482
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.